279 related articles for article (PubMed ID: 9813160)
1. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner.
Kobayashi Y; Miwa S; Merry DE; Kume A; Mei L; Doyu M; Sobue G
Biochem Biophys Res Commun; 1998 Nov; 252(1):145-50. PubMed ID: 9813160
[TBL] [Abstract][Full Text] [Related]
2. [In vitro aggregation and cellular toxicity of mutant androgen receptor protein in spinal and bulbar muscular atrophy].
Kobayashi Y; Li M; Sobue G
Nihon Rinsho; 1999 Apr; 57(4):874-9. PubMed ID: 10222782
[TBL] [Abstract][Full Text] [Related]
3. Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.
Thomas PS; Fraley GS; Damian V; Woodke LB; Zapata F; Sopher BL; Plymate SR; La Spada AR
Hum Mol Genet; 2006 Jul; 15(14):2225-38. PubMed ID: 16772330
[TBL] [Abstract][Full Text] [Related]
4. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: a pathogenic marker.
Banno H; Adachi H; Katsuno M; Suzuki K; Atsuta N; Watanabe H; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2006 Mar; 59(3):520-6. PubMed ID: 16358333
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Tanaka F; Adachi H; Banno H; Suzuki K; Watanabe H; Sobue G
Prog Neurobiol; 2012 Dec; 99(3):246-56. PubMed ID: 22609045
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.
Adachi H; Waza M; Katsuno M; Tanaka F; Doyu M; Sobue G
Neuropathol Appl Neurobiol; 2007 Apr; 33(2):135-51. PubMed ID: 17359355
[TBL] [Abstract][Full Text] [Related]
7. [Molecular pathogenesis of motor neuron diseases].
Sobue G
Nihon Shinkei Seishin Yakurigaku Zasshi; 2001 Feb; 21(1):21-25. PubMed ID: 11400322
[TBL] [Abstract][Full Text] [Related]
8. [Study of androgen receptor expression and neuronal vulnerability in X-linked spinal and bulbar muscular atrophy].
Matsuura T
Hokkaido Igaku Zasshi; 1996 Nov; 71(6):785-99. PubMed ID: 8996845
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis, animal models and therapeutics in spinal and bulbar muscular atrophy (SBMA).
Katsuno M; Adachi H; Waza M; Banno H; Suzuki K; Tanaka F; Doyu M; Sobue G
Exp Neurol; 2006 Jul; 200(1):8-18. PubMed ID: 16513111
[TBL] [Abstract][Full Text] [Related]
10. Pure bulbar motor neuron involvement linked to an abnormal CAG repeat expansion in the androgen receptor gene.
Praline J; Guennoc AM; Malinge MC; de Toffol B; Corcia P
Amyotroph Lateral Scler; 2008 Feb; 9(1):40-2. PubMed ID: 17852020
[TBL] [Abstract][Full Text] [Related]
11. Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.
Banno H; Katsuno M; Suzuki K; Takeuchi Y; Kawashima M; Suga N; Takamori M; Ito M; Nakamura T; Matsuo K; Yamada S; Oki Y; Adachi H; Minamiyama M; Waza M; Atsuta N; Watanabe H; Fujimoto Y; Nakashima T; Tanaka F; Doyu M; Sobue G
Ann Neurol; 2009 Feb; 65(2):140-50. PubMed ID: 19259967
[TBL] [Abstract][Full Text] [Related]
12. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity.
Ellerby LM; Hackam AS; Propp SS; Ellerby HM; Rabizadeh S; Cashman NR; Trifiro MA; Pinsky L; Wellington CL; Salvesen GS; Hayden MR; Bredesen DE
J Neurochem; 1999 Jan; 72(1):185-95. PubMed ID: 9886069
[TBL] [Abstract][Full Text] [Related]
13. [Animal models of neurodegenerative diseases on the road to disease-modifying therapy: spinal and bulbar muscular atrophy].
Sobue G
Rinsho Shinkeigaku; 2007 Nov; 47(11):941-3. PubMed ID: 18210842
[TBL] [Abstract][Full Text] [Related]
14. 17-DMAG ameliorates polyglutamine-mediated motor neuron degeneration through well-preserved proteasome function in an SBMA model mouse.
Tokui K; Adachi H; Waza M; Katsuno M; Minamiyama M; Doi H; Tanaka K; Hamazaki J; Murata S; Tanaka F; Sobue G
Hum Mol Genet; 2009 Mar; 18(5):898-910. PubMed ID: 19066230
[TBL] [Abstract][Full Text] [Related]
15. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy.
Katsuno M; Adachi H; Doyu M; Minamiyama M; Sang C; Kobayashi Y; Inukai A; Sobue G
Nat Med; 2003 Jun; 9(6):768-73. PubMed ID: 12754502
[TBL] [Abstract][Full Text] [Related]
16. Kennedy's disease. Phosphorylation of the polyglutamine-expanded form of androgen receptor regulates its cleavage by caspase-3 and enhances cell death.
LaFevre-Bernt MA; Ellerby LM
J Biol Chem; 2003 Sep; 278(37):34918-24. PubMed ID: 12824190
[TBL] [Abstract][Full Text] [Related]
17. Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy.
Butler R; Leigh PN; McPhaul MJ; Gallo JM
Hum Mol Genet; 1998 Jan; 7(1):121-7. PubMed ID: 9384612
[TBL] [Abstract][Full Text] [Related]
18. Huntingtin-associated protein 1 (HAP1) interacts with androgen receptor (AR) and suppresses SBMA-mutant-AR-induced apoptosis.
Takeshita Y; Fujinaga R; Zhao C; Yanai A; Shinoda K
Hum Mol Genet; 2006 Aug; 15(15):2298-312. PubMed ID: 16782802
[TBL] [Abstract][Full Text] [Related]
19. Pathogenesis-targeting therapeutics for spinal and bulbar muscular atrophy (SBMA).
Suzuki K; Kastuno M; Banno H; Sobue G
Neuropathology; 2009 Aug; 29(4):509-16. PubMed ID: 19486304
[TBL] [Abstract][Full Text] [Related]
20. [Triplet repeat disease, with particular emphasis of spinal and bulbar muscular atrophy (SBMA)].
Sobue G
Rinsho Shinkeigaku; 2000 Dec; 40(12):1193-5. PubMed ID: 11464455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
